CORRECTION article

Front. Immunol., 26 January 2024

Sec. Microbial Immunology

Volume 15 - 2024 | https://doi.org/10.3389/fimmu.2024.1365827

Corrigendum: Antimicrobial resistance in the COVID-19 landscape: is there an opportunity for anti-infective antibodies and antimicrobial peptides?

  • 1. Biotechnology of Macromolecules, Instituto de Productos Naturales y Agrobiología, IPNA (CSIC), San Cristóbal de la Laguna, Spain

  • 2. CytoGene Research & Development LLP, Barabanki, Uttar Pradesh, India

  • 3. Department of Life Sciences, Presidency University, Kolkata, India

  • 4. National Interuniversity Consortium of Materials Science and Technology (INSTM) and Chemistry for Technologies Laboratory, Department of Mechanical and Industrial Engineering, University of Brescia, Brescia, Italy

In the published article, there was an error in the affiliation information about Uttpal Anand [2]. Instead of “Department of Life Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel”, it should be “CytoGene Research & Development LLP, Uttar Pradesh, India”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

SARS-CoV-2, antibiotic resistance, one health approach, global health, antibiotic discovery, antimicrobial peptides, environmental contamination, vaccination

Citation

Pérez de la Lastra JM, Anand U, González-Acosta S, López MR, Dey A, Bontempi E and delaNuez AM (2024) Corrigendum: Antimicrobial resistance in the COVID-19 landscape: is there an opportunity for anti-infective antibodies and antimicrobial peptides?. Front. Immunol. 15:1365827. doi: 10.3389/fimmu.2024.1365827

Received

05 January 2024

Accepted

08 January 2024

Published

26 January 2024

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

15 - 2024

Updates

Copyright

*Correspondence: José M. Pérez de la Lastra, ; Uttpal Anand,

†These authors have contributed equally to this work and share first authorship

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics